Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: evidence for promoter usage within the E7 open reading frame during epithelial differentiation Free

Abstract

Human papillomavirus (HPV) type 16 transcription was analysed by hybridization using I-labelled subgenomic riboprobes, from 26 genital intraepithelial neoplastic (IN) lesions, in formalin-fixed biopsies from 18 different cases. Distinct transcription patterns separable by the presence or absence of late gene transcription were detected. In 12 lesions, late gene expression was absent; HPV transcripts corresponding to the E6 and E7 open reading frame (ORF) were detectable in all basal cells and were usually evenly distributed through all layers of the epithelium. Transcripts corresponding to the E1, E2 and E2/E4 ORFs were present in nine of 12 lesions and displayed a similar distribution. In 14 lesions late gene transcripts were present. E6 and E7 transcripts were detectable basally in all but one lesion. The levels of E7 but not E6 transcripts were markedly increased in the superficial cells of differentiating epithelia, with an identical distribution and at similar levels to those of the E2/E4 transcript. We propose that the most abundant transcript in genital IN lesions containing late gene expression is an E7/E1 ^ E2/E4 transcript corresponding to that reported in HPV-6/11 condylomata and which is derived from a similar promoter within the E7 ORF.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-8-2147
1992-08-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/8/JV0730082147.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-8-2147&mimeType=html&fmt=ahah

References

  1. Anderson L. J., Tsou C., Parker R. A., Chorba T. L., Wulff H., Tattersall P., Mortimer P. P. 1986; Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 24:522–526
    [Google Scholar]
  2. Anderson M. J., Jones S. E., Minson A. C. 1985; Diagnosis of human parvovirus infection by dot-blot hybridisation using cloned viral DNA. Journal of Medical Virology 15:163–172
    [Google Scholar]
  3. Beard C., St Amand J., Astell C. R. 1989; Transient expression of B19 parvovirus gene products in COS-7 cells transfected with B19- SV40 hybrid vectors. Virology 172:659–664
    [Google Scholar]
  4. Brown C. S., Salimans M. M. M., Noteborn M. H. M., Weiland H. T. 1990; Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Research 15:197–211
    [Google Scholar]
  5. Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Diagnostic assays with monoclonal antibodies for the human serum parvoviruslike virus (SPLV). Journal of Hygiene 91:113–130
    [Google Scholar]
  6. Cossart Y. E., Field A. M., Cant B., Widdows D. 1975; Parvovirus-like particles in human sera. Lancet i:72–73
    [Google Scholar]
  7. Haukenes G., Blom M. 1975; False positive rubella virus haemagglutination inhibition reactions: occurrence and disclosure. Medical Microbiology and Immunology 161:99–106
    [Google Scholar]
  8. Kajigaya S., Shimada T., Fujita S., Young N. S. 1989; A genetically engineered cell line that produced empty capsids of B19 (human) parvovirus. Proceedings of the National Academy of Sciences, U.S.A 86:7601–7605
    [Google Scholar]
  9. Kajigaya S., Fujii H., Field A., Anderson S., Rosenfield S., Anderson L. J., Shimada T., Young N. S. 1991; Self assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunologically similar to native virus. Proceedings of the National Academy of Sciences, U.S.A 88:4646–4650
    [Google Scholar]
  10. Lennette E. M., Schmidt N. (editors) 1979 Viral, Rickettsial and Chlamydial Infections. Washington, D.C.: American Public Health Association.;
    [Google Scholar]
  11. Mortimer P. P., Humphries R. K., Moore J. G., Purcell R. H., Young N. S. 1983; A human parvovirus-like virus inhibits haematopoietic colony formation in vitro . Nature, London 302:426–429
    [Google Scholar]
  12. Parrish C. R., Burtonboy G., Carmichael L. E. 1988; Characterization of a non-hemagglutinating mutant of canine parvovirus. Virology 163:230–232
    [Google Scholar]
  13. Sato H., Hirata J., Furukawa M., Kuroda N., Shiraki H., Maeda Y., Okochi K. 1991; Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19. Journal of Virology 65:1667–1672
    [Google Scholar]
  14. Tsao J., Chapman M. S., Agbandje M., Keller W., Smith K., Wa H., Luo M., Smith T. J., Rossmann M. G., Compans R. W., Parrish C. R. 1991; The three-dimensional structure of canine parvovirus and its functional implications. Science 251:1456–1463
    [Google Scholar]
  15. Yoshimoto K., Rosenfeld S., Frickhofen N., Kennedy D., Hills R., Kajigaya S., Young N. S. 1991; A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. Journal of Virology 65:7056–7060
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-8-2147
Loading
/content/journal/jgv/10.1099/0022-1317-73-8-2147
Loading

Data & Media loading...

Most cited Most Cited RSS feed